European Biotech Acquisition Corp. Quarterly Accrued Liabilities, Current in USD from Q1 2021 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: European Biotech Acquisition Corp. quarterly Accrued Liabilities, Current history and growth rate from Q1 2021 to Q4 2022.
European Biotech Acquisition Corp. Accrued Liabilities, Current for the quarter ending December 31, 2022 was $403K, a 9.88% decline year-over-year.

Accrued Liabilities, Current, Quarterly (USD)

Accrued Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$403K	-$44.2K	-9.88%	Dec 31, 2022	10-K	2023-02-28
Q3 2022	$1.14M	+$1.06M	+1273%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$305K	+$176K	+137%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$150K	-$4.44K	-2.88%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$447K			Dec 31, 2021	10-K	2023-02-28
Q3 2021	$83K			Sep 30, 2021	10-Q	2021-11-23
Q2 2021	$129K			Jun 30, 2021	10-Q	2021-08-18
Q1 2021	$154K			Mar 31, 2021	10-Q	2021-06-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.